Xcout Intel
DNA Nanobots
DNA Nanobots, LLC is a biotechnology company founded in Columbus, Ohio, that develops products for targeted therapeutics and functionalized gene delivery.
Subscribe to see DNA Nanobots’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
DNA Nanobots at a glance
DNA Nanobots is a biotechnology company headquartered in United States. Its most recent funding round, Seed, raised $3.5M in December 2025. Xcout tracks 3 named people at DNA Nanobots, including James Lynch (CEO).
DNA Nanobots leadership
- James LynchCEO
- Patrick HalleyCTO Co-Founder
- Chris LucasCSO Co-Founder
DNA Nanobots funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $3.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
DNA Nanobots competitors
A few of DNA Nanobots's closest competitors — see the full list of competitors and alternatives →
ViaNautis Bio Ltd. is a groundbreaking nanomedicine company headquartered in Cambridge, UK, at the forefront of genetic therapies. The company leverages its proprietary polyNaut platform to develop novel products for delivering genetic medicines.
Synthorx, Inc., founded in 2014, is a biotechnology company headquartered in La Jolla, California, that engineered expanded genetic alphabet technologies to discover and develop novel protein therapeutics.
NanoVation Therapeutics is a platform developer headquartered in Vancouver, British Columbia, that partners with leading pharmaceutical and biotech companies to enable genetic medicines.
Myosana Therapeutics, Inc. is a biotechnology research company based in Seattle, Washington, pioneering non-viral gene therapy treatments for muscle diseases.
Tessera Therapeutics is a biotechnology company developing programmable genetic medicines using its Gene Writing technology, which is based on mobile genetic elements to insert, replace, or modify DNA in cells. It aims to develop treatments for genetic diseases and other serious conditions, serving patients who need durable genetic therapies.
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Get DNA Nanobots's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on DNA Nanobots in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access